These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15309680)

  • 1. Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome.
    Robitaille J; Brouillette C; Houde A; Lemieux S; Pérusse L; Tchernof A; Gaudet D; Vohl MC
    J Hum Genet; 2004; 49(9):482-489. PubMed ID: 15309680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study.
    Tai ES; Demissie S; Cupples LA; Corella D; Wilson PW; Schaefer EJ; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):805-10. PubMed ID: 12006394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.
    Brisson D; Ledoux K; Bossé Y; St-Pierre J; Julien P; Perron P; Hudson TJ; Vohl MC; Gaudet D
    Pharmacogenetics; 2002 Jun; 12(4):313-20. PubMed ID: 12042669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia.
    Vohl MC; Lepage P; Gaudet D; Brewer CG; Bétard C; Perron P; Houde G; Cellier C; Faith JM; Després JP; Morgan K; Hudson TJ
    J Lipid Res; 2000 Jun; 41(6):945-52. PubMed ID: 10828087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Québec Family Study.
    Robitaille J; Després JP; Pérusse L; Vohl MC
    Clin Genet; 2003 Feb; 63(2):109-16. PubMed ID: 12630956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of apolipoprotein B are modulated by a gene--diet interaction effect between the LFABP T94A polymorphism and dietary fat intake in French-Canadian men.
    Robitaille J; Brouillette C; Lemieux S; Pérusse L; Gaudet D; Vohl MC
    Mol Genet Metab; 2004 Aug; 82(4):296-303. PubMed ID: 15308127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls.
    Gouni-Berthold I; Giannakidou E; Faust M; Berthold HK; Krone W
    Atherosclerosis; 2005 Dec; 183(2):336-41. PubMed ID: 16285997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil.
    Bossé Y; Pascot A; Dumont M; Brochu M; Prud'homme D; Bergeron J; Després JP; Vohl MC
    Genet Med; 2002; 4(4):311-5. PubMed ID: 12172398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The peroxisome proliferator-activated receptor alpha Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men.
    Paradis AM; Fontaine-Bisson B; Bossé Y; Robitaille J; Lemieux S; Jacques H; Lamarche B; Tchernof A; Couture P; Vohl MC
    Am J Clin Nutr; 2005 Feb; 81(2):523-30. PubMed ID: 15699244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study.
    Tai ES; Corella D; Demissie S; Cupples LA; Coltell O; Schaefer EJ; Tucker KL; Ordovas JM;
    J Nutr; 2005 Mar; 135(3):397-403. PubMed ID: 15735069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis.
    Verdi H; Koytak ES; Onder O; Ergül AA; Cinar K; Idilman R; Erden E; Bozdayi AM; Yurdaydin C; Uzunalimoglu O; Bozkaya H
    J Investig Med; 2005 Nov; 53(7):353-9. PubMed ID: 16297361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peroxisome proliferator-activated receptor alpha L162V mutation is associated with reduced adiposity.
    Bossé Y; Després JP; Bouchard C; Pérusse L; Vohl MC
    Obes Res; 2003 Jul; 11(7):809-16. PubMed ID: 12855749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.
    González Sánchez JL; Serrano Ríos M; Fernández Perez C; Laakso M; Martínez Larrad MT
    Eur J Endocrinol; 2002 Oct; 147(4):495-501. PubMed ID: 12370112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An association between the PPARα-L162V polymorphism and nicotine dependency among patients with schizophrenia.
    Nadalin S; Buretić-Tomljanović A; Rebić J; Pleša I; Šendula Jengić V
    Compr Psychiatry; 2016 Oct; 70():118-24. PubMed ID: 27624431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus.
    Evans D; Aberle J; Wendt D; Wolf A; Beisiegel U; Mann WA
    J Mol Med (Berl); 2001 May; 79(4):198-204. PubMed ID: 11409711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease.
    Wang XL; Oosterhof J; Duarte N
    Cardiovasc Res; 1999 Dec; 44(3):588-94. PubMed ID: 10690291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARalpha L162V polymorphism alters the potential of n-3 fatty acids to increase lipoprotein lipase activity.
    Rudkowska I; Caron-Dorval D; Verreault M; Couture P; Deshaies Y; Barbier O; Vohl MC
    Mol Nutr Food Res; 2010 Apr; 54(4):543-50. PubMed ID: 19937854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome profiles, obesity measures and intake of dietary fatty acids in adults: Tehran Lipid and Glucose Study.
    Shab-Bidar S; Hosseini-Esfahani F; Mirmiran P; Hosseinpour-Niazi S; Azizi F
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():98-108. PubMed ID: 23731333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men.
    Skogsberg J; McMahon AD; Karpe F; Hamsten A; Packard CJ; Ehrenborg E;
    J Intern Med; 2003 Dec; 254(6):597-604. PubMed ID: 14641801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of PPARgamma2 P12A and PPARalpha L162V polymorphisms on glucose and insulin homeostasis: the Québec Family Study.
    Bossé Y; Weisnagel SJ; Bouchard C; Després JP; Pérusse L; Vohl MC
    J Hum Genet; 2003; 48(12):614-621. PubMed ID: 14677049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.